XT
DMAC icon

XTX Topco’s DiaMedica Therapeutics DMAC Stock Holding History

XTX Topco’s Portfolio DMAC Stock Details DMAC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$106K Buy
+15,096
New +$92.8K ﹤0.01% 3514
2026
Q1 		– Sell
-29,415
Closed -$234K – 3935
2025
Q4 		$234K Buy
+29,415
New +$220K 0.01% 2276

Other funds holding DMAC

CLG
Cooperman Leon G $3.55B AUM 41.85% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Millennium Management
Millennium Management New York $276B AUM 44.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
BL
Bleichroeder LP New York $559M AUM 83.7% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Osaic Holdings
Osaic Holdings Scottsdale, Arizona $85.1B AUM 27.35% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

XTX Topco's DMAC Position: Q2 2026 in Review

XTX Topco opened a new position in DiaMedica Therapeutics (DMAC) in Q2 2026: 15,096 shares worth $106K. The stake represents ﹤0.01% of the portfolio and ranks #3514 among its holdings. This is a return to the name: XTX Topco previously reported a position in DMAC as recently as Q4 2025.

XTX Topco first reported a position in DMAC in Q4 2025 and has held it in 2 quarters since. The position peaked at $234K in Q4 2025. 89 funds tracked by Wall St. Rank hold DMAC as of Q2 2026.

  • XTX Topco held 15,096 shares of DiaMedica Therapeutics worth $106K as of Q2 2026.
  • DiaMedica Therapeutics was a new XTX Topco position in Q2 2026.
  • DiaMedica Therapeutics made up ﹤0.01% of XTX Topco's portfolio in Q2 2026, its #3514 holding.
  • XTX Topco first reported a position in DiaMedica Therapeutics in Q4 2025 and has held it in 2 quarters since.
  • XTX Topco's DiaMedica Therapeutics position peaked at $234K in Q4 2025.
  • 89 funds tracked by Wall St. Rank held DiaMedica Therapeutics as of Q2 2026.

Based on XTX Topco's 13F filing for Q2 2026, filed 14 Aug 2026.